TORREYPINES THERAPEUTICS
TorreyPines Therapeutics engages in the discovery and development of small molecule compounds in the United States. Its product portfolio includes both candidates from its drug targeting platforms and in-licensed and acquired product candidates. As of August 31, 2010, its pipeline includes three clinical development programs. It also has three other clinical-stage product candidates, for which it is seeking business development partners, and it has four preclinical product candidates it is developing, three of which are based upon its drug-targeting platforms.
TORREYPINES THERAPEUTICS
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2000-04-01
Address:
La Jolla, California, United States
Country:
United States
Total Employee:
1+
Status:
Active
Total Funding:
81.26 M USD
Similar Organizations
Cytori Therapeutics
Cytori Therapeutics engages in the development of autologous cell therapies.
Investors List
Gimv
Gimv investment in Series C - TorreyPines Therapeutics
Advent International
Advent International investment in Series C - TorreyPines Therapeutics
NIF Ventures
NIF Ventures investment in Series C - TorreyPines Therapeutics
Novartis Venture Fund
Novartis Venture Fund investment in Series C - TorreyPines Therapeutics
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation investment in Series C - TorreyPines Therapeutics
Sorrento Ventures
Sorrento Ventures investment in Series C - TorreyPines Therapeutics
Alta Partners
Alta Partners investment in Series C - TorreyPines Therapeutics